Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
This study will investigate the clinical variables that may be used to predict who among the solid organ transplant recipients will develop cytomegalovirus (CMV) disease after completing antiviral prophylaxis.
|Study Design:||Time Perspective: Retrospective|
|Official Title:||Clinical Predictors of Late-onset CMV Disease in Solid Organ Transplant Recipients: A Strategy to Improve the Benefits and Reduce the Risks of Anti-CMV Prophylaxis|
|Study Start Date:||November 2004|
|Study Completion Date:||June 2007|
|Primary Completion Date:||June 2007 (Final data collection date for primary outcome measure)|
This study will investigate the clinical and laboratory variables that may be used to predict who among the solid organ transplant recipients will develop CMV disease after completing antiviral prophylaxis. This is a retrospective study of patients seen at the Mayo Clinic during the past five years.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00170170
|United States, Minnesota|
|Rochester, Minnesota, United States, 55905|
|Principal Investigator:||Raymund R. Razonable, M.D.||Mayo Clinic|